Advances in understanding the coupling of DNA base modifying enzymes to processes involving base excision repair

Advances in Cancer Research

Volumn 119, Issue , 2013, Pages 63-106

  Wyatt, Michael D ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

5 carboxyl cytosine; 5 hydroxymethylcytosine; 5 methylcytosine; Base excision repair; Cytosine deaminase; DNA methylation; TET dioxygenase; Thymine DNA glycosylase; Uracil

Indexed keywords

5 METHYLCYTOSINE; DIOXYGENASE; DNA BASE; DNA GLYCOSYLTRANSFERASE; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; DOUBLE STRANDED DNA; MESSENGER RNA; PROTEIN MSH2; PROTEIN MSH6; REACTIVE OXYGEN METABOLITE; URACIL DNA GLYCOSIDASE;

ARTICLE; BINDING AFFINITY; BIOTINYLATION; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL DEDIFFERENTIATION; CHROMOSOMAL INSTABILITY; CONFORMATIONAL TRANSITION; DEALKYLATION; DEAMINATION; DECARBOXYLATION; DEMETHYLATION; DNA ADDUCT; DNA DAMAGE; DNA METHYLATION; DNA REPAIR; DNA REPLICATION; DNA STRUCTURE; DNA SYNTHESIS; ELECTROPHILICITY; ELIMINATION REACTION; EMBRYONIC STEM CELL; EPIGENETICS; EXCISION REPAIR; GAIN OF FUNCTION MUTATION; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOMIC INSTABILITY; HELA CELL; HISTONE METHYLATION; HUMAN; IONIZING RADIATION; MAMMAL CELL; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; MUTAGENIC ACTIVITY; NONHUMAN; NUCLEOPHILICITY; OXIDATIVE STRESS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SOMATIC CELL; SUMOYLATION; TRANSIENT EXPRESSION; TUMOR GROWTH;

EID: 84880405089     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-407190-2.00002-2     Document Type: Chapter

References (243)

1. Abdel-Wahab O., Mullally A., Hedvat C., Garcia-Manero G., Patel J., Wadleigh M., et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114:144-147.
2. Almeida K.H., Sobol R.W. A unified view of base excision repair: Lesion-dependent protein complexes regulated by post-translational modification. DNA Repair (Amsterdam) 2007, 6:695-711.
3. Ambrose H.E., Willimott S., Beswick R.W., Dantzer F., de Murcia J.M., Yelamos J., et al. Poly(ADP-ribose) polymerase-1 (Parp-1)-deficient mice demonstrate abnormal antibody responses. Immunology 2009, 127:178-186.
4. An Q., Robins P., Lindahl T., Barnes D.E. C → T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases. The EMBO Journal 2005, 24:2205-2213.
5. Anant S., Davidson N.O. Molecular mechanisms of apolipoprotein B mRNA editing. Current Opinion in Lipidology 2001, 12:159-165.
6. Bader S., Walker M., Harrison D. Most microsatellite unstable sporadic colorectal carcinomas carry MBD4 mutations. British Journal of Cancer 2000, 83:1646-1649.
7. Bader S., Walker M., Hendrich B., Bird A., Bird C., Hooper M., et al. Somatic frameshift mutations in the MBD4 gene of sporadic colon cancers with mismatch repair deficiency. Oncogene 1999, 18:8044-8047.
8. Berg J.M., Tymoczko J.L., Stryer L. Biochemistry 2007, W. H. Freeman, New York.
9. Bergink S., Jentsch S. Principles of ubiquitin and SUMO modifications in DNA repair. Nature 2009, 458:461-467.
10. Bhutani N., Brady J.J., Damian M., Sacco A., Corbel S.Y., Blau H.M. Reprogramming towards pluripotency requires AID-dependent DNA demethylation. Nature 2010, 463:1042-1047.
11. Boehler C., Gauthier L.R., Mortusewicz O., Biard D.S., Saliou J.M., Bresson A., et al. Poly(ADP-ribose) polymerase 3 (PARP3), a newcomer in cellular response to DNA damage and mitotic progression. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:2783-2788.
12. Boland M.J., Christman J.K. Characterization of Dnmt3b: Thymine-DNA glycosylase interaction and stimulation of thymine glycosylase-mediated methyltransferase(s) repair by DNA and RNA. Journal of Molecular Biology 2008, 379:492-504.
13. Boorstein R.J., Chiu L.N., Teebor G.W. Phylogenetic evidence of a role for 5-hydroxymethyluracil-DNA glycosylase in the maintenance of 5-methylcytosine in DNA. Nucleic Acids Research 1989, 17:7653-7661.
14. Boorstein R.J., Cummings A., Marenstein D.R., Chan M.K., Ma Y., Neubert T.A., et al. Definitive identification of mammalian 5-hydroxymethyluracil DNA N-glycosylase activity as SMUG1. The Journal of Biological Chemistry 2001, 276:41991-41997.
15. Booth M.J., Branco M.R., Ficz G., Oxley D., Krueger F., Reik W., et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 2012, 336:934-937.
16. Bransteitter R., Pham P., Scharff M.D., Goodman M.F. Activation-induced cytidine deaminase deaminates deoxycytidine on single-stranded DNA but requires the action of RNase. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:4102-4107.
17. Breen A.P., Murphy J.A. Reactions of oxyl radicals with DNA. Free Radical Biology & Medicine 1995, 18:1033-1077.
18. Cabelof D.C., Ikeno Y., Nyska A., Busuttil R.A., Anyangwe N., Vijg J., et al. Haploinsufficiency in DNA polymerase beta increases cancer risk with age and alters mortality rate. Cancer Research 2006, 66:7460-7465.
19. Cabelof D.C., Raffoul J.J., Nakamura J., Kapoor D., Abdalla H., Heydari A.R. Imbalanced base excision repair in response to folate deficiency is accelerated by polymerase beta haploinsufficiency. The Journal of Biological Chemistry 2004, 279:36504-36513.
20. Caldecott K.W. Single-strand break repair and genetic disease. Nature Reviews. Genetics 2008, 9:619-631.
21. Cannon S.V., Cummings A., Teebor G.W. 5-Hydroxymethylcytosine DNA glycosylase activity in mammalian tissue. Biochemical and Biophysical Research Communications 1988, 151:1173-1179.
22. Cannon-Carlson S.V., Gokhale H., Teebor G.W. Purification and characterization of 5-hydroxymethyluracil-DNA glycosylase from calf thymus. Its possible role in the maintenance of methylated cytosine residues. The Journal of Biological Chemistry 1989, 264:13306-13312.
23. Chen H., Dzitoyeva S., Manev H. Effect of aging on 5-hydroxymethylcytosine in the mouse hippocampus. Restorative Neurology and Neuroscience 2012, 30:237-245.
24. Chen T., Hevi S., Gay F., Tsujimoto N., He T., Zhang B., et al. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nature Genetics 2007, 39:391-396.
25. Chen D., Lucey M.J., Phoenix F., Lopez-Garcia J., Hart S.M., Losson R., et al. T:G mismatch-specific thymine-DNA glycosylase potentiates transcription of estrogen-regulated genes through direct interaction with estrogen receptor alpha. The Journal of Biological Chemistry 2003, 278:38586-38592.
26. Cheng X., Roberts R.J. AdoMet-dependent methylation, DNA methyltransferases and base flipping. Nucleic Acids Research 2001, 29:3784-3795.
27. Chouliaras L., van den Hove D.L., Kenis G., Keitel S., Hof P.R., van Os J., et al. Age-related increase in levels of 5-hydroxymethylcytosine in mouse hippocampus is prevented by caloric restriction. Current Alzheimer Research 2012, 9:536-544.
28. Ciccarone F., Klinger F.G., Catizone A., Calabrese R., Zampieri M., Bacalini M.G., et al. Poly(ADP-ribosyl)ation acts in the DNA demethylation of mouse primordial germ cells also with DNA damage-independent roles. PLoS One 2012, 7:e46927.
29. Cliffe L.J., Kieft R., Southern T., Birkeland S.R., Marshall M., Sweeney K., et al. JBP1 and JBP2 are two distinct thymidine hydroxylases involved in J biosynthesis in genomic DNA of African trypanosomes. Nucleic Acids Research 2009, 37:1452-1462.
30. Cole B.F., Baron J.A., Sandler R.S., Haile R.W., Ahnen D.J., Bresalier R.S., et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA: The Journal of the American Medical Association 2007, 297:2351-2359.
31. Connor E.E., Wyatt M.D. Active-site clashes prevent the human 3-methyladenine DNA glycosylase from improperly removing bases. Chemistry & Biology 2002, 9:1033-1041.
32. Cortazar D., Kunz C., Saito Y., Steinacher R., Schar P. The enigmatic thymine DNA glycosylase. DNA Repair (Amsterdam) 2007, 6:489-504.
33. Cortazar D., Kunz C., Selfridge J., Lettieri T., Saito Y., MacDougall E., et al. Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability. Nature 2011, 470:419-423.
34. Cortellino S., Xu J., Sannai M., Moore R., Caretti E., Cigliano A., et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 2011, 146:67-79.
35. Crott J.W., Liu Z., Choi S.W., Mason J.B. Folate depletion in human lymphocytes up-regulates p53 expression despite marked induction of strand breaks in exons 5-8 of the gene. Mutation Research 2007, 626:171-179.
36. Crott J.W., Liu Z., Keyes M.K., Choi S.W., Jang H., Moyer M.P., et al. Moderate folate depletion modulates the expression of selected genes involved in cell cycle, intracellular signaling and folate uptake in human colonic epithelial cell lines. The Journal of Nutritional Biochemistry 2008, 19:328-335.
37. Dang L., White D.W., Gross S., Bennett B.D., Bittinger M.A., Driggers E.M., et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 2009, 462:739-744.
38. De Vos M., Schreiber V., Dantzer F. The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art. Biochemical Pharmacology 2012, 84:137-146.
39. de Wind N., Dekker M., Berns A., Radman M., te Riele H. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 1995, 82:321-330.
40. Di Noia J.M., Neuberger M.S. Molecular mechanisms of antibody somatic hypermutation. Annual Review of Biochemistry 2007, 76:1-22.
41. Di Noia J.M., Rada C., Neuberger M.S. SMUG1 is able to excise uracil from immunoglobulin genes: Insight into mutation versus repair. The EMBO Journal 2006, 25:585-595.
42. Di Noia J.M., Williams G.T., Chan D.T., Buerstedde J.M., Baldwin G.S., Neuberger M.S. Dependence of antibody gene diversification on uracil excision. The Journal of Experimental Medicine 2007, 204:3209-3219.
43. Doege C.A., Inoue K., Yamashita T., Rhee D.B., Travis S., Fujita R., et al. Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2. Nature 2012, 488:652-655.
44. Dzitoyeva S., Chen H., Manev H. Effect of aging on 5-hydroxymethylcytosine in brain mitochondria. Neurobiology of Aging 2012, 33:2881-2891.
45. Egger G., Jeong S., Escobar S.G., Cortez C.C., Li T.W., Saito Y., et al. Identification of DNMT1 (DNA methyltransferase 1) hypomorphs in somatic knockouts suggests an essential role for DNMT1 in cell survival. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:14080-14085.
46. Ehrlich M., Zhang X.Y., Inamdar N.M. Spontaneous deamination of cytosine and 5-methylcytosine residues in DNA and replacement of 5-methylcytosine residues with cytosine residues. Mutation Research 1990, 238:277-286.
47. Endres M., Biniszkiewicz D., Sobol R.W., Harms C., Ahmadi M., Lipski A., et al. Increased postischemic brain injury in mice deficient in uracil-DNA glycosylase. The Journal of Clinical Investigation 2004, 113:1711-1721.
48. Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
49. Friedberg E.C., Walker G.C., Siede W., Wood R.D., Schultz R.A., Ellenberger T. DNA repair and mutagenesis 2006, ASM Press, Washington, D.C.
50. Fung H., Demple B. A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Molecular Cell 2005, 17:463-470.
51. Gallais R., Demay F., Barath P., Finot L., Jurkowska R., Le Guevel R., et al. Deoxyribonucleic acid methyl transferases 3a and 3b associate with the nuclear orphan receptor COUP-TFI during gene activation. Molecular Endocrinology 2007, 21:2085-2098.
52. Gao Y., Katyal S., Lee Y., Zhao J., Rehg J.E., Russell H.R., et al. DNA ligase III is critical for mtDNA integrity but not Xrcc1-mediated nuclear DNA repair. Nature 2011, 471:240-244.
53. Gaudet F., Hodgson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., et al. Induction of tumors in mice by genomic hypomethylation. Science 2003, 300:489-492.
54. Gommers-Ampt J.H., Teixeira A.J., van de Werken G., van Dijk W.J., Borst P. The identification of hydroxymethyluracil in DNA of Trypanosoma brucei. Nucleic Acids Research 1993, 21:2039-2043.
55. Gommers-Ampt J.H., Van Leeuwen F., de Beer A.L., Vliegenthart J.F., Dizdaroglu M., Kowalak J.A., et al. beta-D-glucosyl-hydroxymethyluracil: A novel modified base present in the DNA of the parasitic protozoan T. brucei. Cell 1993, 75:1129-1136.
56. Grady W.M., Ulrich C.M. DNA alkylation and DNA methylation: Cooperating mechanisms driving the formation of colorectal adenomas and adenocarcinomas?. Gut 2007, 56:318-320.
57. Greer E.L., Shi Y. Histone methylation: A dynamic mark in health, disease and inheritance. Nature Reviews. Genetics 2012, 13:343-357.
58. Gross S., Cairns R.A., Minden M.D., Driggers E.M., Bittinger M.A., Jang H.G., et al. Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. The Journal of Experimental Medicine 2010, 207:339-344.
59. Gu T.P., Guo F., Yang H., Wu H.P., Xu G.F., Liu W., et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 2011, 477:606-610.
60. Gu H., Marth J.D., Orban P.C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 1994, 265:103-106.
61. Guikema J.E., Gerstein R.M., Linehan E.K., Cloherty E.K., Evan-Browning E., Tsuchimoto D., et al. Apurinic/apyrimidinic endonuclease 2 is necessary for normal B cell development and recovery of lymphoid progenitors after chemotherapeutic challenge. Journal of Immunology 2011, 186:1943-1950.
62. Guikema J.E., Linehan E.K., Tsuchimoto D., Nakabeppu Y., Strauss P.R., Stavnezer J., et al. APE1- and APE2-dependent DNA breaks in immunoglobulin class switch recombination. The Journal of Experimental Medicine 2007, 204:3017-3026.
63. Guo J.U., Su Y., Zhong C., Ming G.L., Song H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 2011, 145:423-434.
64. Haffner M.C., Chaux A., Meeker A.K., Esopi D.M., Gerber J., Pellakuru L.G., et al. Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget 2011, 2:627-637.
65. Han L., Yu K. Altered kinetics of nonhomologous end joining and class switch recombination in ligase IV-deficient B cells. The Journal of Experimental Medicine 2008, 205:2745-2753.
66. Hardeland U., Bentele M., Jiricny J., Schar P. Separating substrate recognition from base hydrolysis in human thymine DNA glycosylase by mutational analysis. The Journal of Biological Chemistry 2000, 275:33449-33456.
67. Hardeland U., Steinacher R., Jiricny J., Schar P. Modification of the human thymine-DNA glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. The EMBO Journal 2002, 21:1456-1464.
68. Hasham M.G., Donghia N.M., Coffey E., Maynard J., Snow K.J., Ames J., et al. Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nature Immunology 2010, 11:820-826.
69. Hashimoto H., Vertino P.M., Cheng X. Molecular coupling of DNA methylation and histone methylation. Epigenomics 2010, 2:657-669.
70. Haushalter K.A., Todd Stukenberg M.W., Kirschner M.W., Verdine G.L. Identification of a new uracil-DNA glycosylase family by expression cloning using synthetic inhibitors. Current Biology 1999, 9:174-185.
71. Hayashi I., Sohn K.J., Stempak J.M., Croxford R., Kim Y.I. Folate deficiency induces cell-specific changes in the steady-state transcript levels of genes involved in folate metabolism and 1-carbon transfer reactions in human colonic epithelial cells. The Journal of Nutrition 2007, 137:607-613.
72. Hayatsu H., Shiragami M. Reaction of bisulfite with the 5-hydroxymethyl group in pyrimidines and in phage DNAs. Biochemistry 1979, 18:632-637.
73. He Y.F., Li B.Z., Li Z., Liu P., Wang Y., Tang Q., et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 2011, 333:1303-1307.
74. Helleday T. The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings. Molecular Oncology 2011, 5:387-393.
75. Hendrich B., Hardeland U., Ng H.H., Jiricny J., Bird A. The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 1999, 401:301-304.
76. Holden L.G., Prochnow C., Chang Y.P., Bransteitter R., Chelico L., Sen U., et al. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications. Nature 2008, 456:121-124.
77. Hu X.V., Rodrigues T.M., Tao H., Baker R.K., Miraglia L., Orth A.P., et al. Identification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screen. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:15087-15092.
78. Huang Y., Pastor W.A., Shen Y., Tahiliani M., Liu D.R., Rao A. The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One 2010, 5:e8888.
79. Huang Y., Pastor W.A., Zepeda-Martinez J.A., Rao A. The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine. Nature Protocols 2012, 7:1897-1908.
80. Ide Y., Tsuchimoto D., Tominaga Y., Nakashima M., Watanabe T., Sakumi K., et al. Growth retardation and dyslymphopoiesis accompanied by G2/M arrest in APEX2-null mice. Blood 2004, 104:4097-4103.
81. Imai K., Slupphaug G., Lee W.I., Revy P., Nonoyama S., Catalan N., et al. Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nature Immunology 2003, 4:1023-1028.
82. Inoue A., Zhang Y. Replication-dependent loss of 5-hydroxymethylcytosine in mouse preimplantation embryos. Science 2011, 334:194.
83. Iqbal K., Jin S.G., Pfeifer G.P., Szabo P.E. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:3642-3647.
84. Ito S., Shen L., Dai Q., Wu S.C., Collins L.B., Swenberg J.A., et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 2011, 333:1300-1303.
85. Iyer L.M., Tahiliani M., Rao A., Aravind L. Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 2009, 8:1698-1710.
86. Izumi T., Brown D.B., Naidu C.V., Bhakat K.K., Macinnes M.A., Saito H., et al. Two essential but distinct functions of the mammalian abasic endonuclease. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:5739-5743.
87. Jin S.G., Jiang Y., Qiu R., Rauch T.A., Wang Y., Schackert G., et al. 5-Hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Research 2011, 71:7360-7365.
88. Jin S.-G., Kadam S., Pfeifer G.P. Examination of the specificity of DNA methylation profiling techniques towards 5-methylcytosine and 5-hydroxymethylcytosine. Nucleic Acids Research 2010, 38:e125.
89. Jiricny J. The multifaceted mismatch-repair system. Nature Reviews. Molecular Cell Biology 2006, 7:335-346.
90. Jones P.A. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nature Reviews. Genetics 2012, 13:484-492.
91. Kadaveru K., Protiva P., Greenspan E.J., Kim Y.I., Rosenberg D.W. Dietary methyl donor depletion protects against intestinal tumorigenesis in Apc(Min/+) mice. Cancer Prevention Research (Philadelphia, PA) 2012, 5:911-920.
92. Kangaspeska S., Stride B., Metivier R., Polycarpou-Schwarz M., Ibberson D., Carmouche R.P., et al. Transient cyclical methylation of promoter DNA. Nature 2008, 452:112-115.
93. Kasprzak K.S., Jaruga P., Zastawny T.H., North S.L., Riggs C.W., Olinski R., et al. Oxidative DNA base damage and its repair in kidneys and livers of nickel(II)-treated male F344 rats. Carcinogenesis 1997, 18:271-277.
94. Kavli B., Andersen S., Otterlei M., Liabakk N.B., Imai K., Fischer A., et al. B cells from hyper-IgM patients carrying UNG mutations lack ability to remove uracil from ssDNA and have elevated genomic uracil. The Journal of Experimental Medicine 2005, 201:2011-2021.
95. Kavli B., Otterlei M., Slupphaug G., Krokan H.E. Uracil in DNA-General mutagen, but normal intermediate in acquired immunity. DNA Repair (Amsterdam) 2007, 6:505-516.
96. Kavli B., Slupphaug G., Mol C.D., Arvai A.S., Peterson S.B., Tainer J.A., et al. Excision of cytosine and thymine from DNA by mutants of human uracil-DNA glycosylase. The EMBO Journal 1996, 15:3442-3447.
97. Kemmerich K., Dingler F.A., Rada C., Neuberger M.S. Germline ablation of SMUG1 DNA glycosylase causes loss of 5-hydroxymethyluracil- and UNG-backup uracil-excision activities and increases cancer predisposition of Ung-/-Msh2-/- mice. Nucleic Acids Research 2012, 40:6016-6025.
98. Khare T., Pai S., Koncevicius K., Pal M., Kriukiene E., Liutkeviciute Z., et al. 5-hmC in the brain is abundant in synaptic genes and shows differences at the exon-intron boundary. Nature Structural & Molecular Biology 2012, 19:1037-1043.
99. Klose R.J., Kallin E.M., Zhang Y. JmjC-domain-containing proteins and histone demethylation. Nature Reviews. Genetics 2006, 7:715-727.
100. Knock E., Deng L., Wu Q., Lawrance A.K., Wang X.L., Rozen R. Strain differences in mice highlight the role of DNA damage in neoplasia induced by low dietary folate. The Journal of Nutrition 2008, 138:653-658.
101. Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
102. Ko M., An J., Bandukwala H.S., Chavez L., Aijö T., Pastor W.A., et al. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 2013, 497:122-126.
103. Kohli R.M., Maul R.W., Guminski A.F., McClure R.L., Gajula K.S., Saribasak H., et al. Local sequence targeting in the AID/APOBEC family differentially impacts retroviral restriction and antibody diversification. The Journal of Biological Chemistry 2010, 285:40956-40964.
104. Kraus T.F., Globisch D., Wagner M., Eigenbrod S., Widmann D., Munzel M., et al. Low values of 5-hydroxymethylcytosine (5hmC), the "sixth base," are associated with anaplasia in human brain tumors. International Journal of Cancer 2012, 131:1577-1590.
105. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
106. Krokan H.E., Drablos F., Slupphaug G. Uracil in DNA-Occurrence, consequences and repair. Oncogene 2002, 21:8935-8948.
107. Kronenberg G., Harms C., Sobol R.W., Cardozo-Pelaez F., Linhart H., Winter B., et al. Folate deficiency induces neurodegeneration and brain dysfunction in mice lacking uracil DNA glycosylase. The Journal of Neuroscience 2008, 28:7219-7230.
108. Kulkarni A., McNeill D.R., Gleichmann M., Mattson M.P., Wilson D.M. XRCC1 protects against the lethality of induced oxidative DNA damage in nondividing neural cells. Nucleic Acids Research 2008, 36:5111-5121.
109. Langemeijer S.M., Kuiper R.P., Berends M., Knops R., Aslanyan M.G., Massop M., et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nature Genetics 2009, 41:838-842.
110. Lao V.V., Darwanto A., Sowers L.C. Impact of base analogues within a CpG dinucleotide on the binding of DNA by the methyl-binding domain of MeCP2 and methylation by DNMT1. Biochemistry 2010, 49:10228-10236.
111. Larijani M., Frieder D., Sonbuchner T.M., Bransteitter R., Goodman M.F., Bouhassira E.E., et al. Methylation protects cytidines from AID-mediated deamination. Molecular Immunology 2005, 42:599-604.
112. Lawrance A.K., Deng L., Brody L.C., Finnell R.H., Shane B., Rozen R. Genetic and nutritional deficiencies in folate metabolism influence tumorigenicity in Apcmin/+ mice. The Journal of Nutritional Biochemistry 2007, 18:305-312.
113. Lee Y., Katyal S., Li Y., El-Khamisy S.F., Russell H.R., Caldecott K.W., et al. The genesis of cerebellar interneurons and the prevention of neural DNA damage require XRCC1. Nature Neuroscience 2009, 12:973-980.
114. Li Y.Q., Zhou P.Z., Zheng X.D., Walsh C.P., Xu G.L. Association of Dnmt3a and thymine DNA glycosylase links DNA methylation with base-excision repair. Nucleic Acids Research 2007, 35:390-400.
115. Lin H., Yamada Y., Nguyen S., Linhart H., Jackson-Grusby L., Meissner A., et al. Suppression of intestinal neoplasia by deletion of Dnmt3b. Molecular and Cellular Biology 2006, 26:2976-2983.
116. Lin C., Yang L., Tanasa B., Hutt K., Ju B.G., Ohgi K., et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell 2009, 139:1069-1083.
117. Lindahl T. An N-glycosidase from Escherichia coli that releases free uracil from DNA containing deaminated cytosine residues. Proceedings of the National Academy of Sciences of the United States of America 1974, 71:3649-3653.
118. Lindahl T., Nyberg B. Heat-induced deamination of cytosine residues in deoxyribonucleic acid. Biochemistry 1974, 13:3405-3410.
119. Linhart H.G., Lin H., Yamada Y., Moran E., Steine E.J., Gokhale S., et al. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation and transcriptional silencing. Genes & Development 2007, 21:3110-3122.
120. Linhart H.G., Troen A., Bell G.W., Cantu E., Chao W.H., Moran E., et al. Folate deficiency induces genomic uracil misincorporation and hypomethylation but does not increase DNA point mutations. Gastroenterology 2009, 136:227-235.
121. Liu M., Duke J.L., Richter D.J., Vinuesa C.G., Goodnow C.C., Kleinstein S.H., et al. Two levels of protection for the B cell genome during somatic hypermutation. Nature 2008, 451:841-845.
122. Liu H., Takeda S., Cheng E.H., Hsieh J.J. Biphasic MLL takes helm at cell cycle control: Implications in human mixed lineage leukemia. Cell Cycle 2008, 7:428-435.
123. Lorsbach R.B., Moore J., Mathew S., Raimondi S.C., Mukatira S.T., Downing J.R. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 2003, 17:637-641.
124. Luongo C., Moser A.R., Gledhill S., Dove W.F. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Research 1994, 54:5947-5952.
125. Maiti A., Drohat A.C. Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine potential implications for active demethylation of CpG sites. The Journal of Biological Chemistry 2011, 286:35334-35338.
126. Maiti A., Noon M.S., Mackerell A.D., Pozharski E., Drohat A.C. Lesion processing by a repair enzyme is severely curtailed by residues needed to prevent aberrant activity on undamaged DNA. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:8091-8096.
127. Mangeat B., Turelli P., Caron G., Friedli M., Perrin L., Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003, 424:99-103.
128. Mashiyama S.T., Courtemanche C., Elson-Schwab I., Crott J., Lee B.L., Ong C.N., et al. Uracil in DNA, determined by an improved assay, is increased when deoxynucleosides are added to folate-deficient cultured human lymphocytes. Analytical Biochemistry 2004, 330:58-69.
129. Matsumoto Y., Kim K. Excision of deoxyribose phosphate residues by DNA polymerase β during DNA repair. Science 1995, 269:699-702.
130. Maul R.W., Saribasak H., Martomo S.A., McClure R.L., Yang W., Vaisman A., et al. Uracil residues dependent on the deaminase AID in immunoglobulin gene variable and switch regions. Nature Immunology 2011, 12:70-76.
131. Menissier de Murcia J., Ricoul M., Tartier L., Niedergang C., Huber A., Dantzer F., et al. Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. The EMBO Journal 2003, 22:2255-2263.
132. Metivier R., Gallais R., Tiffoche C., Le Peron C., Jurkowska R.Z., Carmouche R.P., et al. Cyclical DNA methylation of a transcriptionally active promoter. Nature 2008, 452:45-50.
133. Millar C.B., Guy J., Sansom O.J., Selfridge J., MacDougall E., Hendrich B., et al. Enhanced CpG mutability and tumorigenesis in MBD4-deficient mice. Science 2002, 297:403-405.
134. Minegishi Y., Lavoie A., Cunningham-Rundles C., Bedard P.M., Hebert J., Cote L., et al. Mutations in activation-induced cytidine deaminase in patients with hyper IgM syndrome. Clinical Immunology 2000, 97:203-210.
135. Morales-Ruiz T., Ortega-Galisteo A.P., Ponferrada-Marin M.I., Martinez-Macias M.I., Ariza R.R., Roldan-Arjona T. Demeter and repressor of silencing 1 encode 5-methylcytosine DNA glycosylases. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6853-6858.
136. Moran-Crusio K., Reavie L., Shih A., Abdel-Wahab O., Ndiaye-Lobry D., Lobry C., et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20:11-24.
137. Mori T., Hori Y., Dizdaroglu M. DNA base damage generated in vivo in hepatic chromatin of mice upon whole body gamma-irradiation. International Journal of Radiation Biology 1993, 64:645-650.
138. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990, 247:322-324.
139. Munzel M., Globisch D., Bruckl T., Wagner M., Welzmiller V., Michalakis S., et al. Quantification of the sixth DNA base hydroxymethylcytosine in the brain. Angewandte Chemie (International Ed. in English) 2010, 49:5375-5377.
140. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 2000, 102:553-563.
141. Muramatsu M., Sankaranand V.S., Anant S., Sugai M., Kinoshita K., Davidson N.O., et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. The Journal of Biological Chemistry 1999, 274:18470-18476.
142. Nabel C.S., Jia H., Ye Y., Shen L., Goldschmidt H.L., Stivers J.T., et al. AID/APOBEC deaminases disfavor modified cytosines implicated in DNA demethylation. Nature Chemical Biology 2012, 8:751-758.
143. Nackerdien Z., Olinski R., Dizdaroglu M. DNA base damage in chromatin of gamma-irradiated cultured human cells. Free Radical Research Communications 1992, 16:259-273.
144. Neddermann P., Gallinari P., Lettieri T., Schmid D., Truong O., Hsuan J.J., et al. Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase. The Journal of Biological Chemistry 1996, 271:12767-12774.
145. Neddermann P., Jiricny J. Efficient removal of uracil from G.U mispairs by the mismatch-specific thymine DNA glycosylase from HeLa cells. Proceedings of the National Academy of Sciences of the United States of America 1994, 91:1642-1646.
146. Nilsen H., Rosewell I., Robins P., Skjelbred C.F., Andersen S., Slupphaug G., et al. Uracil-DNA glycosylase (UNG)-deficient mice reveal a primary role of the enzyme during DNA replication. Molecular Cell 2000, 5:1059-1065.
147. Nilsen H., Stamp G., Andersen S., Hrivnak G., Krokan H.E., Lindahl T., et al. Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas. Oncogene 2003, 22:5381-5386.
148. Nosho K., Shima K., Irahara N., Kure S., Baba Y., Kirkner G.J., et al. DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer. Clinical Cancer Research 2009, 15:3663-3671.
149. Noushmehr H., Weisenberger D.J., Diefes K., Phillips H.S., Pujara K., Berman B.P., et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010, 17:510-522.
150. Nowarski R., Britan-Rosich E., Shiloach T., Kotler M. Hypermutation by intersegmental transfer of APOBEC3G cytidine deaminase. Nature Structural & Molecular Biology 2008, 15:1059-1066.
151. O'Brien P.J., Ellenberger T. Dissecting the broad substrate specificity of human 3-methyladenine-DNA glycosylase. The Journal of Biological Chemistry 2004, 279:9750-9757.
152. Okazaki I.M., Hiai H., Kakazu N., Yamada S., Muramatsu M., Kinoshita K., et al. Constitutive expression of AID leads to tumorigenesis. The Journal of Experimental Medicine 2003, 197:1173-1181.
153. Olinski R., Zastawny T., Budzbon J., Skokowski J., Zegarski W., Dizdaroglu M. DNA base modifications in chromatin of human cancerous tissues. FEBS Letters 1992, 309:193-198.
154. Ono R., Taki T., Taketani T., Taniwaki M., Kobayashi H., Hayashi Y. LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Research 2002, 62:4075-4080.
155. Ooi S.K., Bestor T.H. The colorful history of active DNA demethylation. Cell 2008, 133:1145-1148.
156. Otterlei M., Warbrick E., Nagelhus T.A., Haug T., Slupphaug G., Akbari M., et al. Post-replicative base excision repair in replication foci. The EMBO Journal 1999, 18:3834-3844.
157. Parikh S.S., Mol C.D., Hosfield D.J., Tainer J.A. Envisioning the molecular choreography of DNA base excision repair. Current Opinion in Structural Biology 1999, 9:37-47.
158. Pastor W.A., Huang Y., Henderson H.R., Agarwal S., Rao A. The GLIB technique for genome-wide mapping of 5-hydroxymethylcytosine. Nature Protocols 2012, 7:1909-1917.
159. Pastor W.A., Pape U.J., Huang Y., Henderson H.R., Lister R., Ko M., et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011, 473:394-397.
160. Pegg A.E. Repair of O(6)-alkylguanine by alkyltransferases. Mutation Research 2000, 462:83-100.
161. Peng Z., Cheng Y., Tan B.C., Kang L., Tian Z., Zhu Y., et al. Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nature Biotechnology 2012, 30:253-260.
162. Penn N.W. Modification of brain deoxyribonucleic acid base content with maturation in normal and malnourished rats. The Biochemical Journal 1976, 155:709-712.
163. Penn N.W., Suwalski R., O'Riley C., Bojanowski K., Yura R. The presence of 5-hydroxymethylcytosine in animal deoxyribonucleic acid. The Biochemical Journal 1972, 126:781-790.
164. Perez C., Martinez-Calle N., Martin-Subero J.I., Segura V., Delabesse E., Fernandez-Mercado M., et al. TET2 mutations are associated with specific 5-methylcytosine and 5-hydroxymethylcytosine profiles in patients with chronic myelomonocytic leukemia. PLoS One 2012, 7:e31605.
165. Perez-Duran P., Belver L., de Yebenes V.G., Delgado P., Pisano D.G., Ramiro A.R. UNG shapes the specificity of AID-induced somatic hypermutation. The Journal of Experimental Medicine 2012, 209:1379-1389.
166. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., et al. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature 2001, 414:660-665.
167. Petersen-Mahrt S.K., Harris R.S., Neuberger M.S. AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification. Nature 2002, 418:99-103.
168. Pettersen H.S., Sundheim O., Gilljam K.M., Slupphaug G., Krokan H.E., Kavli B. Uracil-DNA glycosylases SMUG1 and UNG2 coordinate the initial steps of base excision repair by distinct mechanisms. Nucleic Acids Research 2007, 35:3879-3892.
169. Pfaffeneder T., Hackner B., Truss M., Munzel M., Muller M., Deiml C.A., et al. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angewandte Chemie (International Ed. in English) 2011, 50:7008-7012.
170. Pham P., Bransteitter R., Goodman M.F. Reward versus risk: DNA cytidine deaminases triggering immunity and disease. Biochemistry 2005, 44:2703-2715.
171. Popp C., Dean W., Feng S., Cokus S.J., Andrews S., Pellegrini M., et al. Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency. Nature 2010, 463:1101-1105.
172. Quivoron C., Couronne L., Della Valle V., Lopez C.K., Plo I., Wagner-Ballon O., et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011, 20:25-38.
173. Rada C., Williams G.T., Nilsen H., Barnes D.E., Lindahl T., Neuberger M.S. Immunoglobulin isotype switching is inhibited and somatic hypermutation perturbed in UNG-deficient mice. Current Biology 2002, 12:1748-1755.
174. Rai K., Huggins I.J., James S.R., Karpf A.R., Jones D.A., Cairns B.R. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 2008, 135:1201-1212.
175. Rai K., Sarkar S., Broadbent T.J., Voas M., Grossmann K.F., Nadauld L.D., et al. DNA demethylase activity maintains intestinal cells in an undifferentiated state following loss of APC. Cell 2010, 142:930-942.
176. Ranjit S., Khair L., Linehan E.K., Ucher A.J., Chakrabarti M., Schrader C.E., et al. AID binds cooperatively with UNG and Msh2-Msh6 to Ig switch regions dependent upon the AID C terminus. Journal of Immunology 2011, 187:2464-2475.
177. Rausch J.W., Chelico L., Goodman M.F., Le Grice S.F. Dissecting APOBEC3G substrate specificity by nucleoside analog interference. The Journal of Biological Chemistry 2009, 284:7047-7058.
178. Revy P., Muto T., Levy Y., Geissmann F., Plebani A., Sanal O., et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 2000, 102:565-575.
179. Riccio A., Aaltonen L.A., Godwin A.K., Loukola A., Percesepe A., Salovaara R., et al. The DNA repair gene MBD4 (MED1) is mutated in human carcinomas with microsatellite instability. Nature Genetics 1999, 23:266-268.
180. Rice G.I., Kasher P.R., Forte G.M., Mannion N.M., Greenwood S.M., Szynkiewicz M., et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nature Genetics 2012, 44:1243-1248.
181. Ripley L.S., Drake J.W. Bacteriophage T4 particles are refractory to bisulfite mutagenesis. Mutation Research 1984, 129:149-152.
182. Roa S., Li Z., Peled J.U., Zhao C., Edelmann W., Scharff M.D. MSH2/MSH6 complex promotes error-free repair of AID-induced dU:G mispairs as well as error-prone hypermutation of A:T sites. PLoS One 2010, 5:e11182.
183. Robbiani D.F., Bunting S., Feldhahn N., Bothmer A., Camps J., Deroubaix S., et al. AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Molecular Cell 2009, 36:631-641.
184. Robert I., Dantzer F., Reina-San-Martin B. Parp1 facilitates alternative NHEJ, whereas Parp2 suppresses IgH/c-myc translocations during immunoglobulin class switch recombination. The Journal of Experimental Medicine 2009, 206:1047-1056.
185. Saribasak H., Maul R.W., Cao Z., McClure R.L., Yang W., McNeill D.R., et al. XRCC1 suppresses somatic hypermutation and promotes alternative nonhomologous end joining in Igh genes. The Journal of Experimental Medicine 2011, 208:2209-2216.
186. Saribasak H., Rajagopal D., Maul R.W., Gearhart P.J. Hijacked DNA repair proteins and unchained DNA polymerases. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 2009, 364:605-611.
187. Schiesser S., Hackner B., Pfaffeneder T., Muller M., Hagemeier C., Truss M., et al. Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angewandte Chemie (International Ed. in English) 2012, 51:6516-6520.
188. Schrader C.E., Guikema J.E., Linehan E.K., Selsing E., Stavnezer J. Activation-induced cytidine deaminase-dependent DNA breaks in class switch recombination occur during G1 phase of the cell cycle and depend upon mismatch repair. Journal of Immunology 2007, 179:6064-6071.
189. Senejani A.G., Dalal S., Liu Y.F., Nottoli T.P., McGrath J.M., Clairmont C.S., et al. Y265C DNA polymerase beta knockin mice survive past birth and accumulate base excision repair intermediate substrates. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:6632-6637.
190. Shen J.C., Rideout W.M., Jones P.A. High frequency mutagenesis by a DNA methyltransferase. Cell 1992, 71:1073-1080.
191. Shen J.C., Rideout W.M., Jones P.A. The rate of hydrolytic deamination of 5-methylcytosine in double-stranded DNA. Nucleic Acids Research 1994, 22:972-976.
192. Sibani S., Melnyk S., Pogribny I.P., Wang W., Hiou-Tim F., Deng L., et al. Studies of methionine cycle intermediates (SAM, SAH), DNA methylation and the impact of folate deficiency on tumor numbers in Min mice. Carcinogenesis 2002, 23:61-65.
193. Simsek D., Furda A., Gao Y., Artus J., Brunet E., Hadjantonakis A.K., et al. Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair. Nature 2011, 471:245-248.
194. Sobol R.W., Prasad R., Evenski A., Baker A., Yang X.P., Horton J.K., et al. The lyase activity of the DNA repair protein β-polymerase protects from DNA-damage-induced cytotoxicity. Nature 2000, 405:807-810.
195. Song J., Medline A., Mason J.B., Gallinger S., Kim Y.I. Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Research 2000, 60:5434-5440.
196. Soulas-Sprauel P., Le Guyader G., Rivera-Munoz P., Abramowski V., Olivier-Martin C., Goujet-Zalc C., et al. Role for DNA repair factor XRCC4 in immunoglobulin class switch recombination. The Journal of Experimental Medicine 2007, 204:1717-1727.
197. Sousa M.M., Krokan H.E., Slupphaug G. DNA-uracil and human pathology. Molecular Aspects of Medicine 2007, 28:276-306.
198. Steinacher R., Schar P. Functionality of human thymine DNA glycosylase requires SUMO-regulated changes in protein conformation. Current Biology 2005, 15:616-623.
199. Steine E.J., Ehrich M., Bell G.W., Raj A., Reddy S., van Oudenaarden A., et al. Genes methylated by DNA methyltransferase 3b are similar in mouse intestine and human colon cancer. The Journal of Clinical Investigation 2011, 121:1748-1752.
200. Stivers J.T., Jiang Y.L. A mechanistic perspective on the chemistry of DNA repair glycosylases. Chemical Reviews 2003, 103:2729-2759.
201. Sugo N., Aratani Y., Nagashima Y., Kubota Y., Koyama H. Neonatal lethality with abnormal neurogenesis in mice deficient in DNA polymerase beta. The EMBO Journal 2000, 19:1397-1404.
202. Szwagierczak A., Bultmann S., Schmidt C.S., Spada F., Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Research 2010, 38:e181.
203. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
204. Tebbs R.S., Flannery M.L., Meneses J.J., Hartmann A., Tucker J.D., Thompson L.H., et al. Requirement for the Xrcc1 DNA base excision repair gene during early mouse development. Developmental Biology 1999, 208:513-529.
205. Thillainadesan G., Chitilian J.M., Isovic M., Ablack J.N., Mymryk J.S., Tini M., et al. TGF-beta-dependent active demethylation and expression of the p15(ink4b) tumor suppressor are impaired by the ZNF217/CoREST complex. Molecular Cell 2012, 46:636-649.
206. Tini M., Benecke A., Um S.J., Torchia J., Evans R.M., Chambon P. Association of CBP/p300 acetylase and thymine DNA glycosylase links DNA repair and transcription. Molecular Cell 2002, 9:265-277.
207. Toyokuni S., Mori T., Dizdaroglu M. DNA base modifications in renal chromatin of Wistar rats treated with a renal carcinogen, ferric nitrilotriacetate. International Journal of Cancer 1994, 57:123-128.
208. Trasler J., Deng L., Melnyk S., Pogribny I., Hiou-Tim F., Sibani S., et al. Impact of Dnmt1 deficiency, with and without low folate diets, on tumor numbers and DNA methylation in Min mice. Carcinogenesis 2003, 24:39-45.
209. Ulrich C.M., Potter J.D. Folate and cancer-Timing is everything. JAMA: The Journal of the American Medical Association 2007, 297:2408-2409.
210. Um S., Harbers M., Benecke A., Pierrat B., Losson R., Chambon P. Retinoic acid receptors interact physically and functionally with the T:G mismatch-specific thymine-DNA glycosylase. The Journal of Biological Chemistry 1998, 273:20728-20736.
211. Unnikrishnan A., Raffoul J.J., Patel H.V., Prychitko T.M., Anyangwe N., Meira L.B., et al. Oxidative stress alters base excision repair pathway and increases apoptotic response in apurinic/apyrimidinic endonuclease 1/redox factor-1 haploinsufficient mice. Free Radical Biology & Medicine 2009, 46:1488-1499.
212. Vainio S., Genest P.A., ter Riet B., van Luenen H., Borst P. Evidence that J-binding protein 2 is a thymidine hydroxylase catalyzing the first step in the biosynthesis of DNA base J. Molecular and Biochemical Parasitology 2009, 164:157-161.
213. Valinluck V., Sowers L.C. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Research 2007, 67:946-950.
214. Vartanian J.P., Guetard D., Henry M., Wain-Hobson S. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 2008, 320:230-233.
215. Ventrella-Lucente L.F., Unnikrishnan A., Pilling A.B., Patel H.V., Kushwaha D., Dombkowski A.A., et al. Folate deficiency provides protection against colon carcinogenesis in DNA polymerase beta haploinsufficient mice. The Journal of Biological Chemistry 2010, 285:19246-19258.
216. Vesely C., Tauber S., Sedlazeck F.J., von Haeseler A., Jantsch M.F. Adenosine deaminases that act on RNA induce reproducible changes in abundance and sequence of embryonic miRNAs. Genome Research 2012, 22:1468-1476.
217. Wang H., Guan S., Quimby A., Cohen-Karni D., Pradhan S., Wilson G., et al. Comparative characterization of the PvuRts1I family of restriction enzymes and their application in mapping genomic 5-hydroxymethylcytosine. Nucleic Acids Research 2011, 39:9294-9305.
218. Wang R.Y., Kuo K.C., Gehrke C.W., Huang L.H., Ehrlich M. Heat- and alkali-induced deamination of 5-methylcytosine and cytosine residues in DNA. Biochimica et Biophysica Acta 1982, 697:371-377.
219. Ward P.S., Patel J., Wise D.R., Abdel-Wahab O., Bennett B.D., Coller H.A., et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010, 17:225-234.
220. Waters T.R., Gallinari P., Jiricny J., Swann P.F. Human thymine DNA glycosylase binds to apurinic sites in DNA but is displaced by human apurinic endonuclease 1. The Journal of Biological Chemistry 1999, 274:67-74.
221. Wiebauer K., Jiricny J. In vitro correction of G.T mispairs to G.C pairs in nuclear extracts from human cells. Nature 1989, 339:234-236.
222. Wilson S.H., Kunkel T.A. Passing the baton in base excision repair. Nature Structural Biology 2000, 7:176-178.
223. Wong E., Yang K., Kuraguchi M., Werling U., Avdievich E., Fan K., et al. Mbd4 inactivation increases Cright-arrowT transition mutations and promotes gastrointestinal tumor formation. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:14937-14942.
224. Wu X., Stavnezer J. DNA polymerase beta is able to repair breaks in switch regions and plays an inhibitory role during immunoglobulin class switch recombination. The Journal of Experimental Medicine 2007, 204:1677-1689.
225. Wyatt M.D., Allan J.M., Lau A.Y., Ellenberger T.E., Samson L.D. 3-methyladenine DNA glycosylases: Structure, function, and biological importance. Bio Essays 1999, 21:668-676.
226. Wyatt G.R., Cohen S.S. The bases of the nucleic acids of some bacterial and animal viruses: The occurrence of 5-hydroxymethylcytosine. The Biochemical Journal 1953, 55:774-782.
227. Wyatt M.D., Pittman D.L. Methylating agents and DNA repair responses: Methylated bases and sources of strand breaks. Chemical Research in Toxicology 2006, 19:1580-1594.
228. Xanthoudakis S., Miao G., Wang F., Pan Y.C., Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. The EMBO Journal 1992, 11:3323-3335.
229. Xanthoudakis S., Smeyne R.J., Wallace J.D., Curran T. The redox/DNA repair protein, Ref-1, is essential for early embryonic development in mice. Proceedings of the National Academy of Sciences of the United States of America 1996, 93:8919-8923.
230. Xu W., Yang H., Liu Y., Yang Y., Wang P., Kim S.H., et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 2011, 19:17-30.
231. Yamada Y., Jackson-Grusby L., Linhart H., Meissner A., Eden A., Lin H.J., et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:13580-13585.
232. Yan C.T., Boboila C., Souza E.K., Franco S., Hickernell T.R., Murphy M., et al. IgH class switching and translocations use a robust non-classical end-joining pathway. Nature 2007, 449:478-482.
233. Yang H., Liu Y., Bai F., Zhang J.Y., Ma S.H., Liu J., et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013, 32:663-669.
234. Yi C., Yang C.G., He C. A non-heme iron-mediated chemical demethylation in DNA and RNA. Accounts of Chemical Research 2009, 42:519-529.
235. Yoshikawa K., Okazaki I.M., Eto T., Kinoshita K., Muramatsu M., Nagaoka H., et al. AID enzyme-induced hypermutation in an actively transcribed gene in fibroblasts. Science 2002, 296:2033-2036.
236. Yu Z., Genest P.A., ter Riet B., Sweeney K., DiPaolo C., Kieft R., et al. The protein that binds to DNA base J in trypanosomatids has features of a thymidine hydroxylase. Nucleic Acids Research 2007, 35:2107-2115.
237. Zampieri M., Guastafierro T., Calabrese R., Ciccarone F., Bacalini M.G., Reale A., et al. ADP-ribose polymers localized on Ctcf-Parp1-Dnmt1 complex prevent methylation of Ctcf target sites. The Biochemical Journal 2012, 441:645-652.
238. Zampieri M., Passananti C., Calabrese R., Perilli M., Corbi N., De Cave F., et al. Parp1 localizes within the Dnmt1 promoter and protects its unmethylated state by its enzymatic activity. PLoS One 2009, 4:e4717.
239. Zan H., Casali P. AID- and Ung-dependent generation of staggered double-strand DNA breaks in immunoglobulin class switch DNA recombination: A post-cleavage role for AID. Molecular Immunology 2008, 46:45-61.
240. Zhu J.K. Active DNA demethylation mediated by DNA glycosylases. Annual Review of Genetics 2009, 43:143-166.
241. Zhu B., Zheng Y., Hess D., Angliker H., Schwarz S., Siegmann M., et al. 5-methylcytosine-DNA glycosylase activity is present in a cloned G/T mismatch DNA glycosylase associated with the chicken embryo DNA demethylation complex. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:5135-5139.
242. Zhuang J., Jones A., Lee S.H., Ng E., Fiegl H., Zikan M., et al. The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer. PLoS Genetics 2012, 8:e1002517.
243. Zingg J.M., Shen J.C., Yang A.S., Rapoport H., Jones P.A. Methylation inhibitors can increase the rate of cytosine deamination by (cytosine-5)-DNA methyltransferase. Nucleic Acids Research 1996, 24:3267-3275.